Peptron Company Description

Peptron, Inc. engages in the development of peptide-based medicines.

The company’s technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug.

It develops PAb 001 for cancer therapy; SR-Exenatide (PT320) for Parkinson’s and other neurodegenerative disease; SR-Octreotide for the treatment of acromegaly; and Dernak filler for bioequivalence.

Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.

Peptron, Inc.

Country	South Korea
Founded	1997
Industry	Biological Products, Except Diagnostic Substances
CEO	Ho-Il Choi

Contact Details

Address: 37-24, Yuseong-daero 1628 beon-gil Daejeon, 34054 South Korea
Phone	82 4 2360 8880
Website	peptron.co.kr

Stock Details

Ticker Symbol	087010
Exchange	KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	2836

Key Executives

Name	Position
Ho-Il Choi	Chief Executive Officer